Search
ambroxol; ambroxolum
Indications:
- experimental drug for Parkinson's disease [2]
Pharmacokinetics:
- crosses blood brain barrier
Mechanism of action:
- mucolytic agent
- increases beta-glucocerebrosidase & alpha synuclein levels in CSF
General
mucolytic agent
Database Correlations
PUBCHEM cid=2132
References
- PubChem: 2132
- Nackerdien Z
Repurposed Mucolytic Shows Promise for Neuroprotection in Parkinson's Disease.
- Changes in GCase levels occurred in patients with and without GBA1 mutations.
MedPage Today. anuary 29, 2020
https://www.medpagetoday.org/neurology/parkinsonsdisease/84594